Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 25.9.2024STADA Arzneimittel AG (STD)3609ETeriflunomide Stada 14 mg filmom obalené tablety (tbl flm 28x14 mg (lblis. Al/PVC/Al/OPA))2.9.2024U
 24.9.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)9756DSitagliptin/Metformin Teva 50 mg/1000 mg (tbl flm 56x50 mg/1000 mg (blis.PVC/PVDC/Al))20.9.2024O
 24.9.2024Pharmevid s.r.o. (PEV)4483ESunitinib Pharmevid 50 mg (cps dur 30x50 mg (fľ.HDPE))30.9.2024U
 24.9.2024Pharmevid s.r.o. (PEV)4481ESunitinib Pharmevid 25 mg (cps dur 30x25 mg (fľ.HDPE))30.9.2024U
 24.9.2024Pharmevid s.r.o. (PEV)4479ESunitinib Pharmevid 12,5 mg (cps dur 30x12,5 mg (fľ.HDPE))30.9.2024U
 24.9.2024Fresenius Kabi Deutschland GmbH (FRK-1)4535ETyenne 162 mg injekčný roztok v naplnenom pere (sol ira 4x0,9 ml/162 mg (pero napl.))24.9.2024R
 24.9.2024Fresenius Kabi s.r.o. (FRK-CZ-3)58746Ciprofloxacin Kabi 400 mg/200 ml (sol inf 10x200 ml/400 mg (fľ.PE))26.9.2024R
 24.9.2024Fresenius Kabi s.r.o. (FRK-CZ-3)47122Sodium chloride Fresenius Kabi 0,9 % (sol inf 20x500 ml (vak Freeflex))26.9.2024R
 24.9.2024Fresenius Kabi s.r.o. (FRK-CZ-3)7393DNorepinephrine Kabi 1 mg/ml (con inf 10x10 ml (amp.skl.))26.9.2024R
 23.9.2024ARDEZ Pharma, spol. s r.o. (ARZ)5050DTadard 5 mg (tbl flm 28x5 mg (blis.PVC/PVDC/Al))30.9.2024O
 23.9.2024ARDEZ Pharma, spol. s r.o. (ARZ)5054DTadard 20 mg (tbl flm 8x20 mg (blis.PVC/PVDC/Al))30.9.2024O
 23.9.2024Berlin-Chemie AG (BCE)0649BMIG-400 (tbl flm 30x400 mg (blis.PVC/Al fólia v škatuľke))17.9.2024U
 23.9.2024STADA Arzneimittel AG (STD)5916EAzelastín/Flutikazón STADA (aer nau 1x23 g (fľ.skl.jantár.))10.9.2024U
 22.9.2024Biosimilar Collaborations Ireland Limited (BTT)9996CFulphila 6 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,6 ml/6 mg (striek.inj.napl.skl. s chráničom ihly))20.9.2024R
 22.9.2024Biosimilar Collaborations Ireland Limited (BTT)0510DSemglee 100 jednotiek/ml injekčný roztok v naplnenom pere (sol inj 10 (2x5)x3 ml/300 jednotiek (náplň skl. v pere))20.9.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)